MLYS logo

Mineralys Therapeutics, Inc. (MLYS) return on equity

annual ROE:

-82.24%-40.86%(-98.74%)
December 31, 2024

Summary

  • As of today (September 16, 2025), MLYS annual return on equity is -82.24%, with the most recent change of -40.86% (-98.74%) on December 31, 2024.
  • During the last 3 years, MLYS annual ROE has risen by +1486.72% (+94.76%).
  • MLYS annual ROE is now -186.34% below its all-time high of 95.25%, reached on December 1, 2020.

Performance

MLYS ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLYSprofitability metrics

quarterly ROE:

-69.45%-1.54%(-2.27%)
June 30, 2025

Summary

  • As of today (September 16, 2025), MLYS quarterly return on equity is -69.45%, with the most recent change of -1.54% (-2.27%) on June 30, 2025.
  • Over the past year, MLYS quarterly ROE has dropped by -26.96% (-63.45%).
  • MLYS quarterly ROE is now -164.07% below its all-time high of 108.40%, reached on September 30, 2022.

Performance

MLYS quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLYSprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

MLYS ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-98.7%-63.5%
3 y3 years+94.8%+68.9%
5 y5 years-186.3%+40.5%

MLYS ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-98.7%+94.8%-164.1%+68.9%
5 y5-year-186.3%+94.8%-164.1%+68.9%
alltimeall time-186.3%+94.8%-164.1%+68.9%

MLYS ROE History

DateAnnualQuarterly
Jun 2025
-
-69.45%(+2.3%)
Mar 2025
-
-67.91%(-1.7%)
Dec 2024
-82.24%(+98.7%)
-69.05%(+22.6%)
Sep 2024
-
-56.33%(+32.6%)
Jun 2024
-
-42.49%(+32.4%)
Mar 2024
-
-32.10%(+6.5%)
Dec 2023
-41.38%
-30.15%(+26.7%)
Sep 2023
-
-23.79%(+35.2%)
DateAnnualQuarterly
Jun 2023
-
-17.59%(-39.6%)
Mar 2023
-
-29.13%(-58.8%)
Dec 2022
-53.00%(-96.6%)
-70.62%(-165.1%)
Sep 2022
-
108.40%(-148.5%)
Jun 2022
-
-223.39%(+91.5%)
Dec 2021
-1568.96%(-1747.2%)
-
Dec 2021
-
-116.67%
Dec 2020
95.25%
-

FAQ

  • What is Mineralys Therapeutics, Inc. annual return on equity?
  • What is the all time high annual ROE for Mineralys Therapeutics, Inc.?
  • What is Mineralys Therapeutics, Inc. annual ROE year-on-year change?
  • What is Mineralys Therapeutics, Inc. quarterly return on equity?
  • What is the all time high quarterly ROE for Mineralys Therapeutics, Inc.?
  • What is Mineralys Therapeutics, Inc. quarterly ROE year-on-year change?

What is Mineralys Therapeutics, Inc. annual return on equity?

The current annual ROE of MLYS is -82.24%

What is the all time high annual ROE for Mineralys Therapeutics, Inc.?

Mineralys Therapeutics, Inc. all-time high annual return on equity is 95.25%

What is Mineralys Therapeutics, Inc. annual ROE year-on-year change?

Over the past year, MLYS annual return on equity has changed by -40.86% (-98.74%)

What is Mineralys Therapeutics, Inc. quarterly return on equity?

The current quarterly ROE of MLYS is -69.45%

What is the all time high quarterly ROE for Mineralys Therapeutics, Inc.?

Mineralys Therapeutics, Inc. all-time high quarterly return on equity is 108.40%

What is Mineralys Therapeutics, Inc. quarterly ROE year-on-year change?

Over the past year, MLYS quarterly return on equity has changed by -26.96% (-63.45%)
On this page